Skip to content
Screener
Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$44.74M-6.7%-$8.28M+98.1%-$40.37M-$38M+37.4%-$41.93M+75.8%
$2.32M-12.7%$2.2M-57.1%$2.74M-3.7%$2.46M-41.3%$2.66M-24.0%
$9.26M-22.1%$4.46M-51.5%$9.59M-40.2%$10.98M-39.8%$11.9M-30.9%
-$35.58M-21.1%-$44.69M-1.4%-$19.07M+37.8%-$18.71M+58.9%-$29.38M+45.9%
$1.56M+183%$3.04M+119%$861K-46.8%$0$550K-62.8%
$40.07M+58.5%$35.86M-20.7%$26.03M-55.3%$18.9M-18.0%$25.28M-67.1%
$255K$1.44M-26.6%$1.47M+80.9%
-$7.4M-336%$6.96M+131%$1.66M+108%-$4.09M
-$37.14M-24.1%-$47.73M-5.0%-$19.93M+38.2%-$18.62M+58.3%-$29.93M+46.3%

FAQ

How much cash does Pacific Biosciences of California generate?
Pacific Biosciences of California (PACB) generated -$118.1M in operating cash flow over the trailing twelve months.
What is Pacific Biosciences of California's free cash flow?
After $5.5M of capital expenditures, Pacific Biosciences of California's free cash flow was -$123.4M over the trailing twelve months, up 19.0% year over year.
Where does Pacific Biosciences of California's cash flow data come from?
Every line is extracted from Pacific Biosciences of California's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.